Vast Therapeutics

Vast Therapeutics is a preclinical biotechnology company headquartered in Morrisville, North Carolina. Employing 11 individuals, Vast Therapeutics focuses on developing innovative therapies for respiratory diseases. Vast Therapeutics specializes in airway immunology, aiming to disrupt the cycle of infection and chronic inflammation. Their technology platform centers around nitric oxide, utilizing stable prodrugs known for their potent antimicrobial activity. By combining these compounds with advanced inhalation formulations, Vast Therapeutics delivers targeted drug candidates directly to the lungs, addressing the unique needs of various patient groups. Their nitric oxide-based approach offers a potential alternative to traditional antibiotics, leveraging the body's natural immune response to combat microbial pathogens. These compounds are designed to circumvent antimicrobial resistance mechanisms commonly associated with conventional antibiotics. For further information, please visit Vast Therapeutics' website at vasttherapeutics.com.